Since it was first launched, the ZEISS At Lisa trifocal intraocular lens (IOL) has accumulated a wealth of clinical evidence in scientific literature attesting to its robust visual and refractive performance and predictability. With more than 85 peer-reviewed publications by 60 different authors detailing the results of over 9,000 eyes from 4,500 implanted patients, ZEISS At Lisa Trifocal offers surgeons an IOL that has proven consistently to deliver excellent outcomes in terms of visual quality and patient satisfaction.*
Using asymmetric light allocation to ensure best visual outcome at all three distances, the At Lisa trifocal IOL has repeatedly demonstrated spectacle independence at higher than 90%* with several studies demonstrating full spectacle independence.*
Contact: ZEISS Surgical Account Manager
*ZEISS information on file.